A new study conducted at Columbia University Medical Center (CUMC) has revealed some of the underlying mechanisms that may increase the risk of heart disease in people with sleep apnoea. The study also found that statins
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:47Cholesterol-lowering statins may lower risk of heart disease in people with apnoea
A recent study found that cervical cancer patients without enlarged lymph nodes could benefit from SPECT-MRI imaging of their sentinel lymph nodes (SLNs) to assess whether metastases are present.
Cervical cancer is the fourth most common cancer in women worldwide, with more than 500,000 new cases globally each year. According to a 2014 University of Maryland study, cervical cancer affects 18.6 women per 100,000 in the United States. Early diagnosis is critical. Although surgical removal and examination of the sentinel lymph nodes remains the most accurate way to determine whether the cancer has spread to the lymph nodes, SPECT-MRI imaging may reduce false negative MRI findings in early-stage patients and potentially save some from invasive diagnostic procedures.
Researchers at the University Medical Center Utrecht, Netherlands, used Tc-99m-nanocolloid SPECT-MRI fusion for the assessment of SLNs (for size and absence of sharp demarcation) in patients with early-stage cervical cancer.
Jacob P. Hoogendam, MD, the corresponding author of the study, notes,
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:33SPECT-MRI fusion minimizes surgery for diagnosis of early-stage cervical cancer patients
At conhIT – Connecting Healthcare IT, Europe’s leading event for the Health IT industry which takes place from 19 to 21 April in Berlin – a competition will be presenting an award for the best health app once again. This event, part of the internationally recognized AppCircus series, will be taking place for the second time, and is regarded as the world’s biggest competition for mHealth apps. Taking part gives companies and mHealth app developers an opportunity to present their products to an outstanding audience and to increase awareness of their companies in the Health IT sector. At conhIT 2016 more than 7,500 visitors and some 400 exhibitors are expected to attend. The competition will be looking for an app that assists the daily work of medical professionals, nurses and patients and can be used in Europe in hospitals, rehab centres, care homes and general patient care. The award ceremony will take place on 20 April 2016 in the mobile health zone at conhIT. This section of the exhibition focuses on innovations and trends in mobile health applications. The winner of the conhIT AppCircus competition will be nominated for the Mobile Premier Awards, the world’s biggest app exhibition at the Mobile World Congress in Barcelona.
www.conhit.com
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:41The conhIT AppCircus goes in search of the best health app
In a paper recently published, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
Dr. Andrew Bottomley, Head of the EORTC Quality of Life Department and senior investigator of this study says,
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:50Optimal care for older cancer patients should target relevant HRQOL domains
A new hybrid molecule developed in the lab at the NYU Tandon School of Engineering shows promise for treating breast cancer by serving as a
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:36Hybrid molecule delivers a blow to malignant cells
Ductal carcinoma in situ (DCIS) is described as a very early form of breast cancer, where cancer cells are present in milk ducts, but have not yet invaded the surrounding breast tissue. Around 4,800 people are diagnosed with DCIS in the UK each year and the main form of treatment is surgery followed by radiotherapy.
Ongoing public debate about the harm caused by mammography screening through over-diagnosis has led to controversy over the value of screening for and treatment of DCIS. A major question has been the extent to which diagnosis and treatment of DCIS may prevent the occurrence of invasive breast cancer in the future.
The researchers analysed data on 5,243,658 women aged 50-64 who were screened over a four year period across 84 screening units in the UK
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:44Breast screening programme effective in preventing some invasive cancers
Researchers examined the internal design of syringes to see if variations affected the transmission of hepatitis C virus.
As many as 21 million people worldwide inject drugs, putting them at heightened risk for infection from blood-borne pathogens such as the hepatitis C virus (HCV), especially if syringes are shared.
A newer type of syringe designed to reduce HCV transmission by decreasing the so-called dead space
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:52New syringe design not particularly effective at curbing spread of Hepatitis C virus
Researchers at MIT and Boston Children’s Hospital have developed a system that can take MRI scans of a patient’s heart and, in a matter of hours, convert them into a tangible, physical model that surgeons can use to plan surgery. The models could provide a more intuitive way for surgeons to assess and prepare for the anatomical idiosyncrasies of individual patients. ‘Our collaborators are convinced that this will make a difference,’ says Polina Golland, a professor of electrical engineering and computer science at MIT, who led the project. ‘The phrase I heard is that surgeons see with their hands,’ that the perception is in the touch.’ This fall, seven cardiac surgeons at Boston Children’s Hospital will participate in a study intended to evaluate the models’ usefulness. Danielle Pace, an MIT graduate student in electrical engineering and computer science, is first author on the paper and spearheaded the development of the software that analyses the MRI scans. Mehdi Moghari, a physicist at Boston Children’s Hospital, developed new procedures that increase the precision of MRI scans tenfold, and Andrew Powell, a cardiologist at the hospital, leads the project’s clinical work. MRI data consist of a series of cross sections of a three-dimensional object. Like a black-and-white photograph, each cross section has regions of dark and light, and the boundaries between those regions may indicate the edges of anatomical structures. Then again, they may not. Determining the boundaries between distinct objects in an image is one of the central problems in computer vision, known as ‘image segmentation.’ But general-purpose image-segmentation algorithms aren’t reliable enough to produce the very precise models that surgical planning requires. Typically, the way to make an image-segmentation algorithm more precise is to augment it with a generic model of the object to be segmented. Human hearts, for instance, have chambers and blood vessels that are usually in roughly the same places relative to each other. That anatomical consistency could give a segmentation algorithm a way to weed out improbable conclusions about object boundaries. The problem with that approach is that many of the cardiac patients at Boston Children’s Hospital require surgery precisely because the anatomy of their hearts is irregular. Inferences from a generic model could obscure the very features that matter most to the surgeon. In the past, researchers have produced printable models of the heart by manually indicating boundaries in MRI scans. But with the 200 or so cross sections in one of Moghari’s high-precision scans, that process can take eight to 10 hours. ‘They want to bring the kids in for scanning and spend probably a day or two doing planning of how exactly they’re going to operate,’ Golland says. ‘If it takes another day just to process the images, it becomes unwieldy.’ Pace and Golland’s solution was to ask a human expert to identify boundaries in a few of the cross sections and allow algorithms to take over from there. Their strongest results came when they asked the expert to segment only a small patch -one-ninth of the total area – of each cross section. In that case, segmenting just 14 patches and letting the algorithm infer the rest yielded 90 percent agreement with expert segmentation of the entire collection of 200 cross sections. Human segmentation of just three patches yielded 80 percent agreement. ‘I think that if somebody told me that I could segment the whole heart from eight slices out of 200, I would not have believed them,’ Golland says. ‘It was a surprise to us.’ Together, human segmentation of sample patches and the algorithmic generation of a digital, 3-D heart model takes about an hour. The 3-D-printing process takes a couple of hours more. Currently, the algorithm examines patches of unsegmented cross sections and looks for similar features in the nearest segmented cross sections. But Golland believes that its performance might be improved if it also examined patches that ran obliquely across several cross sections. This and other variations on the algorithm are the subject of ongoing research.
MIThttp://tinyurl.com/pz4su4s
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:30Personalized heart models for surgical planning
A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.
Study lead investigator Sarah Prinsloo, Ph.D., assistant professor Palliative, Rehabilitation, and Integrative Medicine at MD Anderson, identified the location of brain activity that contributes to the physical and emotional aspects of chronic pain, which allowed patients to modify their own brain activity through electroencephalogram (EEG) biofeedback. EEG tracks and records brain wave patterns by attaching small metal discs with thin wires on the scalp, and then sending signals to a computer to record the results.
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:39Neurofeedback reduces pain, increases quality of life for cancer patients suffering from chemotherapy-induced neuropathy
Scientists have developed an easy-to-use computer program that can quickly analyse bacterial DNA from a patient
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:47New laptop program can identify drug resistance from bacterial genomes
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.